1. Home
  2. BGLC vs PRPO Comparison

BGLC vs PRPO Comparison

Compare BGLC & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$4.14

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$23.76

Market Cap

32.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
PRPO
Founded
2017
N/A
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
32.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
PRPO
Price
$4.14
$23.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
205.4K
8.8K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,465,006.00
$22,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.21
30.95
52 Week Low
$2.01
$3.90
52 Week High
$15.60
$28.50

Technical Indicators

Market Signals
Indicator
BGLC
PRPO
Relative Strength Index (RSI) 38.24 52.24
Support Level $3.98 $22.10
Resistance Level $4.23 $25.03
Average True Range (ATR) 0.18 1.22
MACD 0.02 -0.23
Stochastic Oscillator 27.78 47.16

Price Performance

Historical Comparison
BGLC
PRPO

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: